Eicke Latz to Coronary Artery Disease
This is a "connection" page, showing publications Eicke Latz has written about Coronary Artery Disease.
Connection Strength
0.170
-
Niyonzima N, Bakke SS, Gregersen I, Holm S, Sandanger ?, Orrem HL, Sporsheim B, Ryan L, Kong XY, Dahl TB, Skjelland M, S?rensen KK, Rokstad AM, Yndestad A, Latz E, Gullestad L, Andersen G?, Dam?s JK, Aukrust P, Mollnes TE, Halvorsen B, Espevik T. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis. EBioMedicine. 2020 Oct; 60:102985.
Score: 0.125
-
L?bbering N, Krogmann A, Jansen F, Latz E, Nickenig G, Zimmer S. Cyclodextrin reduces cholesterol crystal uptake by circulating monocytes in patients undergoing coronary angiography. PLoS One. 2025; 20(12):e0338635.
Score: 0.045